Myocardial depression associated with pneumococcal septic shock reversed by levosimendan

Anaesthesia and Intensive Care

Volumn 35, Issue 3, 2007, Pages 409-413

  Ramaswamykanive, H ^a,b   Bihari, D ^a,b   Solano, T R ^a  

^a PRINCE OF WALES HOSPITAL   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Levosimendan; Septic hypodynamic shock

Indexed keywords

ACTIVATED PROTEIN C; C REACTIVE PROTEIN; CEFTRIAXONE; DOBUTAMINE; LAXATIVE; LEVOSIMENDAN; MEROPENEM; METARAMINOL; METRONIDAZOLE; NORADRENALIN; PENICILLIN G; PROCALCITONIN; VANCOMYCIN; VASOPRESSIN;

ABDOMINAL PAIN; ABDOMINAL RADIOGRAPHY; AGED; ARTICLE; BOLUS INJECTION; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONSTIPATION; CRYSTALLOID; DISEASE SEVERITY; DRUG DOSE INCREASE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ELECTROCARDIOGRAM; FEMALE; GASTROESOPHAGEAL REFLUX; HEART INDEX; HEART OUTPUT; HEART PRELOAD; HEMOFILTRATION; HUMAN; HYPOTENSION; LAPAROTOMY; LEUKOCYTE COUNT; LOOSE FECES; LUNG FLUID; LUNG GAS EXCHANGE; MYOCARDIAL DISEASE; PLEURA EFFUSION; SEPTIC SHOCK; SMALL INTESTINE OBSTRUCTION; SOUTH AFRICA; THORAX RADIOGRAPHY; URINARY TRACT INFECTION; VITAL SIGN;

EID: 34250612671     PISSN: 0310057X     EISSN: None     Source Type: Journal    
DOI: 10.1177/0310057x0703500316     Document Type: Article

References (9)

1. De Luca L, Colucci WS, Nieminen MS, Massie BM, Gheorghiade M. Evidence-based use of levosimendan in different clinical settings. Eur Heart J 2006; 27:1908-1920.
2. Pettila Ville. Levosimendan in patients with severe sepsis or septic shock in progress (Helsinki University Hospital - Randomized, placebo-controlled one center study).
3. Noto A, Giacomini M, Palandi A, L Stabile, Reali- Forster C, Iapichino G. Levosimendan in septic cardiac failure. Intensive Care Med 2005; 31:164-165.
4. Matejovic M, Krouzecky A, Radej J, Novak I. Successful reversal of resistent hypodynamic septic shock with levosimendan. Acta Anaesthesiol Scand 2005; 49:127.
5. Plochl W, Rajek A. The use of the novel calcium sensitizer levosimendan in critically ill patients. Anaesth Intensive Care 2004; 32:471-475.
6. MICROMEDEX® Healthcare Series, Thomson Healthcare, Inc.
7. Russell JA. Management of sepsis. N Engl J Med 2006; 355:1699-1713.
8. Dellinger RP, Carlet JM, Masur H, Gerlach H, Calandra T, Cohen J et al. Surviving Sepsis Campaign guidelines for the management of severe sepsis and septic shock. Intensive Care Med 2004; 30:536-555.
9. Behrends M, Peters J. The calcium sensitizer levosimendan attenuates endotoxin evoked myocardial dysfunction in isolated guinea pig hearts. Intensive Care Med 2003; 29:1802-1807.